Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-994,676
Closed -$24.6M 919
2024
Q2
$24.6M Buy
994,676
+1,626
+0.2% +$46.2K 0.01% 311
2024
Q1
$32.7M Sell
993,050
-29,816
-3% -$1.01M 0.02% 269
2023
Q4
$37.2M Sell
1,022,866
-214,381
-17% -$7.36M 0.02% 247
2023
Q3
$45.4M Sell
1,237,247
-4,047
-0.3% -$161K 0.03% 253
2023
Q2
$47.6M Buy
1,241,294
+4,350
+0.4% +$161K 0.03% 252
2023
Q1
$50.7M Sell
1,236,944
-14,987
-1% -$626K 0.03% 245
2022
Q4
$43.4M Buy
1,251,931
+280,732
+29% +$9.82M 0.03% 259
2022
Q3
$27M Buy
+971,199
New +$31.5M 0.02% 308

Other funds holding ADNT

Ken Fisher's ADNT Position: Q3 2024 in Review

Ken Fisher sold out of Adient (ADNT) in Q3 2024, closing a stake of 994,676 shares — an estimated $24.6M sold.

Ken Fisher first reported a position in ADNT in Q3 2022 and held it in 8 quarters. The position peaked at $50.7M in Q1 2023. 260 funds tracked by Wall St. Rank hold ADNT as of Q3 2024.

  • Ken Fisher reported no remaining Adient position as of Q3 2024 after selling out during the quarter.
  • Ken Fisher sold 994,676 Adient shares in Q3 2024, an estimated $24.6M.
  • Ken Fisher first reported a position in Adient in Q3 2022 and held it in 8 quarters.
  • Ken Fisher's Adient position peaked at $50.7M in Q1 2023.
  • 260 funds tracked by Wall St. Rank held Adient as of Q3 2024.

Based on Fisher Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.